PBMCs from T2D patients were stimulated for 4 h by PMA/ionomycin with brefeldin A, then T-cell production of IL-17 and IFN-γ and expression of SLAMF3 were measured by flow cytometry. This evidence concerns the gene LY9 and type 2 diabetes mellitus.